Fred E Cohen Insider Trading $PGNY Progyny, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Fred E Cohen.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).

Fred E Cohen in Progyny, Inc.

Trading Symbol: PGNY
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of Fred E Cohen: Director
Holdings: 6,000 shares
Latest Transaction: Oct 27 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Fred E Cohen in Progyny, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 27 2020PGNYProgyny, Inc.Cohen Fred EDirectorOption ExerciseA27.9589424,987894
Oct 27 2020PGNYProgyny, Inc.Cohen Fred EDirectorOption ExerciseA27.9527,000754,65027,000
Oct 27 2020PGNYProgyny, Inc.Cohen Fred EDirectorGrantA0.006,00006,0000 to 6 K

Page:   1